Oxford Biomedica Announces Successful Equity Placing to Fuel Global Expansion

Deal News | Aug 15, 2025 | White & Case LLP

Oxford Biomedica Announces Successful Equity Placing to Fuel Global Expansion

White & Case LLP, a prominent global law firm, played a critical advisory role in the equity placing carried out by Oxford Biomedica plc (OXB), a global cell and gene therapy CDMO. The London-listed company executed an equity placement that represents 13.1 percent of its issued share capital. The funds raised from this placement are earmarked for strategic investments meant to expand Oxford Biomedica's global contract development and manufacturing organization (CDMO) network, with a significant focus on the United States market. Jefferies took on the role of global coordinator and joint bookrunner, while RBC Capital Markets served as joint bookrunner in this transaction. The advisory team from White & Case was led by partner Jonathan Parry, with significant contributions from partner Laura Sizemore, counsel Bob Lehner, and associate George Davie.

Sectors

  • Biotechnology
  • Legal Advisory
  • Investment Banking

Geography

  • United Kingdom – Oxford Biomedica is a UK-based company listed on the London Stock Exchange.
  • United States – The future expansion of Oxford Biomedica's CDMO network particularly targets the US market.

Industry

  • Biotechnology – Oxford Biomedica operates in the cell and gene therapy space, which is a significant segment of the biotechnology industry.
  • Legal Advisory – White & Case LLP is a law firm involved in providing legal advice for financial transactions such as equity placements.
  • Investment Banking – Jefferies and RBC Capital Markets are featured as financial entities, acting as global coordinator and joint bookrunners, respectively, facilitating the equity placement.

Financials

  • 13.1 percent of share capital – The proportion of issued share capital involved in the equity placing by Oxford Biomedica.

Participants

NameRoleTypeDescription
Oxford Biomedica plcTarget CompanyCompanyA global cell and gene therapy CDMO with a presence on the London Stock Exchange.
White & Case LLPLegal AdvisorCompanyA global law firm advising on the equity placing transaction.
JefferiesGlobal Coordinator and Joint BookrunnerCompanyAn investment banking firm responsible for overseeing the equity placement.
RBC Capital MarketsJoint BookrunnerCompanyAn investment banking firm collaborating in the process of the equity placement.
Jonathan Parry, Laura Sizemore, Bob Lehner, George DavieAdvisory Team MembersPeopleMembers of White & Case LLP's team providing legal advisory on the transaction.